GAD1 and depressive symptom measurement: Moreover, inhibitory and excitatory amygdaloid circuits were found to be affected in patients with depression, bipolar disorder, or schizophrenia, which was paralleled by a decrease in GAD67 and an increase in VGLUT levels in various nuclei of the amygdala in all patients (Varea et al., 2012).